Yamaguchi Financial Group, Inc. news

   Watch this stock
Showing stories 1 - 2 of about 2   

Articles published

8418 1,323.00 -13.00 (-0.97%)
price chart
Plotting an executive route
Ms Hsu, newly promoted to chief operating officer of Sanrio, which has $5bn in annual revenues, now combines her role as president of Sanrio Inc, the Japanese group's North American subsidiary (the US accounts for 20 per cent of sales), with global ...
FDA Approves Overactive Bladder Treatment Myrbetriq™ (mirabegron) from Astellas
NORTHBROOK, Ill., June 28, 2012 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the U.S. Food and Drug Administration (FDA) has approved Myrbetriq™ ...